Heart failure & cardiomyopathiesCross-sectional study

The impact of country income level on the management of heart failure with preserved ejection fraction: an international survey

ESC Heart FailPublished

  • web-based survey
  • international
  • distributed worldwide from May to July 2023

Authors' conclusion

National income level is associated with major differences in diagnostic testing, medication access, specialist involvement, and multi-disciplinary care for HFpEF. These disparities highlight the need for scalable, resource-adapted strategies to optimize HFpEF care globally.

Study context

Population
Physicians managing heart failure with preserved ejection fraction (HFpEF), worldwidephysicians from 91 countries completed the survey (median age 42 years, 61% male)
Participants
1,459 physicians
Exposure
Countries categorized according to the 2023 World Bank income classifications

Main finding

As reported in the abstract

Type of clinician managing HFpEF
  • cardiologists more frequently involved in upper-middle-income countries (UMICs) and lower-middle-income countries (LMICs)/low-income countries (LICs) than high-income countries (HICs)

Observational data: associations, not effects.

Further findings

OutcomeHICsUMICsLMICsLICs
Proportion of HFpEF among HF patients40%Not reported in the abstractNot reported in the abstractNot reported in the abstract
Screening for coronary artery disease in new HFpEF casesNot reported in the abstract40%Not reported in the abstractNot reported in the abstract
Multi-disciplinary HF programmes62%Not reported in the abstractNot reported in the abstractNot reported in the abstract
  • Proportion of HFpEF among HF patients: elsewhere 30%
  • Proportion of HFpEF among HF patients: P < .001
  • Screening for coronary artery disease in new HFpEF cases: LMICs/LICs 22%
  • Multi-disciplinary HF programmes: LMICs/LICs 24%
  • Multi-disciplinary HF programmes: P < .001

Use of natriuretic peptides and availability of echocardiographic parameters

Use of natriuretic peptides varied significantly across settings, as did the availability of echocardiographic parameters, which was highest in HICs

Medication availability

SGLT2 inhibitors widely available across all groups
88%
Availability of ACE inhibitors, ARBs, MRAs, and loop diuretics showed clear income-related differences

Original publication

The impact of country income level on the management of heart failure with preserved ejection fraction: an international survey. ESC Heart Fail. Published 19 January 2026. doi:10.1093/eschf/xvag031

Summarised from the published abstract; every number is checked against it